PRO-231

· Laboratorios Sophia S.A de C.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-231, covering 2025-06-15 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects [Phase 1]

See pricing